AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glytab M 1 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Elder Pharmaceuticals Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glytab M 1 mg/500 mg Tablet

Diabetic patients may benefit from using GlucoMet, a dual-action antidiabetic medication. This combination therapy, available as a 1mg/500mg tablet, effectively manages type 2 diabetes in adults by regulating blood glucose levels. Administer GlucoMet with food, consistently at the same time daily for optimal results. Dosage is determined individually by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to complications including kidney impairment, vision loss, neuropathy, and limb amputation. GlucoMet is only one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle changes significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, or tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also reported in some patients. Consult your doctor before use if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart problems. GlucoMet's suitability for pregnant or breastfeeding individuals requires prior medical consultation. Regular blood glucose monitoring, along with periodic blood tests for cell counts and liver function, is recommended.

Uses of Glytab M 1 mg/500 mg Tablet

Managing type 2 diabetes

Major Benefits of Glytab M 1 mg/500 mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glytab M 1 mg/500 mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glytab M 1 mg/500 mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glytab M 1 mg/500 mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glytab M 1 mg/500 mg tablets with a meal.

How Glytab M 1 mg/500 mg Tablet works:

Glytab M, a 1 mg/500 mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glytab M 1 mg/500 mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glytab M 1 mg/500 mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Administration of Glytab M 1 mg/500 mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glytab M 1 mg/500 mg tablets, potentially requiring dosage modification. Consult a physician for guidance. Glytab M 1 mg/500 mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glytab M 1 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glytab M 1 mg/500 mg Tablet :

Should you forget a Glytab M 1 mg/500 mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glytab M 1 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glytab M 1 mg/500 mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glytab M 1 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytab M 1 mg/500 mg and seek immediate medical attention.
Glytab M 1 mg/500 mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glytab M 1 mg/500 mg Tablets may cause common side effects including hypoglycemia (low blood sugar), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glytab M 1 mg/500 mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, annual Vitamin B12 supplementation is recommended by some researchers.
Glytab M 1 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glytab M 1 mg/500 mg Tablet with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glytab M 1 mg/500 mg Tabl...
23
MRP 29
19% off